Pro 2014-019 (Jianfeng Group's 2013 Annual Dividend Announcement)
Release time:
2020-08-05
Securities Code: 600668 Securities Abbreviation: Jianfeng Group Announcement No.: Pro 2014-019
Bond Abbreviation: 13 Peak 01 Bond Code: 122227
Zhejiang Jianfeng Group Co., Ltd.
2013 Profit Distribution Implementation Announcement
The Board of Directors and all directors of the Company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and shall bear individual and joint liabilities for the authenticity, accuracy and completeness of its contents .
Important Note:
● Cash Dividend Per Share Before and After Tax Deduction
Units: yuan
cash dividend per share (before tax deduction) |
0.18 |
cash dividend per share (after tax deduction) |
0.171 |
● Equity Registration Date
Equity Registration Date |
July 24, 2014 |
● Derights (ex-dividend) Date: july 25, 2014
● Cash Dividend Payment Date
Cash Dividend Payment Date |
July 25, 2014 |
1. The Session of the Shareholders' General Meeting Passing the Distribution and Capital Transfer Plan and time
Zhejiang Jianfeng Group Co., Ltd.'s 2013 profit distribution plan was reviewed and approved by the company's 2013 annual shareholders' meeting held on June 6, 2014. The announcement of the resolution of the general meeting of shareholders was published in China Securities Journal, Shanghai Securities News and the website of Shanghai Stock Exchange (http://www.sse.com.cn ) on June 7, 2014.
2. Distribution Plan
(I) Issuance Year: 2013
(II) Issuance Scope:
After closing in Shanghai Stock Exchange on the afternoon of July 24, 2014, in Shanghai Branch of China Securities Depository and Clearing Corporation Limited (hereinafter referred to: zhongdeng Shanghai Branch) registered all shareholders of the Company.
This distribution is based on 344,083,828 shares of share capital at the end of 2013, and a cash dividend of 1.8 yuan (including tax) will be distributed to all shareholders for every 10 shares, and 1.71 yuan for every 10 shares after tax deduction. A total dividend of 61935089.04 yuan was distributed.
(III) Tax Deduction Statement
1 . For cash dividends of individual shareholders (including securities investment funds), according to the relevant provisions of the Notice on Issues Concerning the Implementation of Differentiated Individual Income Tax Policies for Dividends of Listed Companies (Caishui [2012 ] 85 ), the company temporarily withholds personal income tax at the rate of 5% . After tax deduction, the actual cash dividend per share is 0. ,171 yuan. If the holding period of a shareholder is within 1 months of (including 1 months of ), the full amount of dividend income shall be included in the taxable income, and the actual tax rate shall 160 20% ; The holding period is from 1 months of to 1 years of (including 1 years of ), effective tax rate 10% ; If the holding period exceeds 1 years, the effective tax rate 5% . When an individual (including a securities investment fund) transfers shares, Zhongdeng Shanghai Branch calculates the actual tax payable according to the holding period, and the part exceeding the withheld tax shall be deducted and transferred to Zhongdeng Shanghai Branch from the personal capital account by the securities company and other share custodian institutions. Zhongdeng Shanghai Branch shall pay the company within 5 working days of the 174 of the following month, and the company shall report and pay the tax to the competent tax authority within the statutory reporting period.
2,Cash dividends for qualified foreign institutional investors (QFII ), according to the relevant provisions of the notice on issues related to withholding and remitting enterprise income tax on dividends, bonuses and interest paid by Chinese resident enterprises to QFII (Guo Shui Han [2009 ] No. 47 ) (hereinafter referred to as the "notice"), the company shall withhold and remit enterprise income tax at a tax rate of 10% of , and the actual cash dividend per share after tax deduction shall be 0.162 yuan. If the relevant shareholder considers that the dividend income received by him is subject to any tax treaty (arrangement) treatment, the shareholder may, in accordance with the provisions of the Notice, apply to the competent tax authorities on his own initiative after the dividend has been received.
3. For company shareholders (including institutional investors) who belong to the meaning of resident enterprises under the "Enterprise Income Tax Law", their income tax is paid by themselves, and the actual cash dividend is RMB 0.18 per share.1.
Distribution Plan Implementation Date
(I)Equity Registration Date
| Equity Registration Date |
July 24, 2014 |
ex-rights (ex-dividend) date: july 25, 2014
(III)Cash Dividend Payment Date
| Cash Dividend Payment Date |
July 25, 2014 |
Distribution Object
as of July 24, 2014 (date of registration of shares) after the closing of the shanghai stock exchange in the afternoon, all shareholders of the Company registered in the Shanghai Branch of China Securities Depository and Clearing Corporation Limited.3.
Dividends and Capital Increment Implementation Measures
(I) The cash dividends of Jinhua Tongji State-owned Assets Investment Co., Ltd., a shareholder of the Company, are directly distributed by the Company.(II) the cash dividends of other shareholders of the company other than Jinhua Tongji State-owned Assets Investment Co., Ltd., the company entrusts Zhongdeng Shanghai Branch to register and register with the Shanghai Stock Exchange through its capital clearing system. Distribute to shareholders who have handled designated transactions. Investors who have completed a fully designated transaction may receive cash dividends at their designated securities business department on the dividend payment date, while shareholders' dividends that have not completed the designated transaction are temporarily kept by Zhongdeng Shanghai Branch and will be distributed after the designated transaction is completed.
4.
Relevant Consultation Measures
Address: Board of Directors Office of Jianfeng Building, 88 Wujiang East Road, Jinhua City, Zhejiang ProvinceTel: 0579-82324699; Fax: 0579-278
5.
Reference Document CatalogueResolutions and Announcements of the 2013 Annual General Meeting of the Company.
Zhejiang Jianfeng Group Co., Ltd.
Board of Directors
July 21, 2014
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page